What You Should Know:
- Nectin Therapeutics Ltd., (Nectin) a biotechnology company developing novel targeted immunotherapies to address resistance to approved immune-oncology treatments, announced it has extended its Series A financing to over $25 million. IBF and Peregrine Ventures led the round, with participation from aMoon Fund and other existing investors.
- The funding will be used to support the ongoing clinical evaluation of NTX1088, and to further advance the company’s pipeline of
Read More
aMoon
Lyfegen Raises $8M for Value-Based Contracting for High-Cost Drugs
What You Should Know:
- Lyfegen, a global health tech SaaS company driving the world’s transition from volume to value-based healthcare for high-cost drugs raises $8M in Series A financing round led by aMoon, with additional participation from APEX Ventures and others.
- Lyfegen’s value-based contracting software is used by healthcare payers and leading pharma companies, including Novartis, Roche, MSD, Bristol Myers Squibb (BMS) and Johnson & Johnson.
Value-Based
Read More
Eleos Closes $20M to Unlock CareOps Automation for Behavioral Health
What You Should Know:
- Eleos Health has announced a $20 million Series A round, co-led by F-Prime Capital and Eight Roads Ventures, bringing their total raise to $28 million.
- Eleos Health is a behavioral health application for voice AI, operating ambiently in the background of mental health clinician-patient conversations. It’s in production use with 20+ care providers and health plans, with a goal of unlocking up to 30% more mental health care provider capacity as the U.S.
Read More
Omada Health Raises $192M to Expand Digital Therapeutics for Chronic Disease
What You Should Know:
- Omada Health, a chronic care integrated healthcare provider, today announced its $192M in Series E funding round led by Fidelity Management & Research Company with participation from aMoon, existing investors Perceptive Advisors, Wellington Management, Civilization Ventures, and others.
- Omada Health will utilize the funding to accelerate hiring at all levels to meet growing customer demands, a technological roadmap for care and coaching personalization to
Read More
Israeli Startup MDClone Lands $26M to Expand Healthcare Data Sandbox
MDClone, an Israeli-based provider of the world’s first healthcare data sandbox has raised $26 million in Series B funding led by aMoon with participation from existing investors OrbiMed Israel Partners and Lightspeed Venture Partners. MDClone plans to utilize the funding to further develop its existing platform and build new products and novel approaches leveraging data across its global network, as well as accelerate sales and marketing efforts.Healthcare Data Sandbox: Explore and Discover
Read More
aMoon II Raises $600M Digital Health Fund to Invest in Mid to Late-Stage Companies
Israeli-based health tech and life sciences venture fund aMoon II has raised $600 million from investors and aims to raise up to $750 million by its close in February, Reuters reported. The fund's objective is to generate strong investment returns by partnering with promising mid-late-stage companies in Israel and in select other global centers of healthtech innovation.aMoon II Investment FocusFounded in 2018, aMoon II secured a $250 million investment commitment from Credit Suisse’s asset
Read More
